CN Stock MarketDetailed Quotes

Amoy Diagnostics (300685)

Watchlist
  • 20.08
  • +0.18+0.90%
Market Closed May 15 15:00 CST
7.83BMarket Cap22.02P/E (TTM)

Amoy Diagnostics (300685) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
-4.32%260.35M
8.01%1.2B
2.08%865.63M
6.69%579.34M
16.63%272.09M
6.27%1.11B
19.84%847.97M
18.38%543.02M
19.53%233.29M
23.91%1.04B
Operating revenue
-4.32%260.35M
8.01%1.2B
2.08%865.63M
6.69%579.34M
16.63%272.09M
6.27%1.11B
19.84%847.97M
18.38%543.02M
19.53%233.29M
23.91%1.04B
Other operating revenue
----
123.87%10.39M
----
117.10%6.52M
----
-53.55%4.64M
----
-39.70%3M
----
2.42%9.99M
Total operating cost
-2.10%168.27M
-1.20%784.42M
-6.01%560.75M
-6.45%358.79M
2.44%171.88M
6.76%793.98M
14.08%596.6M
17.82%383.54M
21.11%167.79M
12.32%743.67M
Operating cost
1.60%45.67M
23.28%208.51M
8.71%140.72M
14.96%92.68M
23.97%44.95M
1.11%169.15M
11.56%129.44M
7.28%80.62M
15.17%36.26M
13.18%167.29M
Operating tax surcharges
-8.26%3.01M
163.40%13.18M
167.96%9.93M
173.10%6.98M
313.89%3.28M
7.10%5M
25.10%3.7M
24.66%2.56M
1.88%791.51K
25.46%4.67M
Operating expense
-28.26%51.52M
-6.90%334.05M
-2.59%245.48M
-7.01%149.13M
9.73%71.81M
8.90%358.82M
13.04%252M
11.08%160.38M
21.16%65.44M
8.46%329.49M
Administration expense
-21.33%16.27M
0.97%72.92M
-1.52%57.37M
-0.82%43.67M
2.39%20.68M
11.36%72.21M
10.36%58.26M
24.88%44.03M
36.28%20.2M
4.10%64.85M
Financial expense
171.34%7.4M
20.09%-21.82M
-124.97%-25.13M
-135.90%-24.21M
-217.92%-10.37M
-5.65%-27.31M
50.41%-11.17M
55.73%-10.26M
-803.82%-3.26M
13.92%-25.85M
-Interest expense (Financial expense)
19.34%401.35K
44.26%1.93M
58.34%1.43M
107.02%1.05M
9.57%336.3K
12.06%1.34M
7.01%906.16K
-21.72%508.59K
-4.76%306.92K
20.34%1.2M
-Interest Income (Financial expense)
13.91%-6.33M
-16.09%-30.85M
-19.77%-23.43M
-23.66%-15.87M
-19.85%-7.35M
-38.65%-26.58M
-48.57%-19.56M
-51.79%-12.84M
-67.87%-6.14M
-213.90%-19.17M
Research and development
6.91%44.41M
-17.83%177.59M
-19.46%132.38M
-14.77%90.53M
-14.12%41.54M
6.35%216.11M
9.03%164.36M
15.62%106.21M
30.75%48.36M
16.44%203.22M
Credit Impairment Loss
160.97%975.69K
13.55%-26.12M
-244.22%-26.83M
-4.97%-5.73M
-306.30%-1.6M
-468.44%-30.22M
-21.68%-7.79M
-26.74%-5.45M
121.30%775.67K
39.15%-5.32M
Asset Impairment Loss
-77.76%14.72K
38.88%-4.98M
99.99%-462.03
100.70%55.92K
1,222.22%66.22K
39.73%-8.15M
-5,783.80%-7.97M
-3,045.07%-7.96M
154.62%5.01K
-4,373.69%-13.52M
Adjustment items of total operating cost
----
----
----
--0.01
----
----
---0.01
----
----
----
Other net revenue
219.73%5.98M
118.72%4.12M
-17.68%1.51M
214.54%2.18M
-80.20%1.87M
-1,655.29%-21.99M
-84.68%1.83M
-94.11%693.5K
6.51%9.45M
-98.69%1.41M
Fair value change income
-33.24%1.21M
-34.68%5.73M
-25.46%4.78M
-30.11%3.24M
-30.67%1.81M
4.46%8.77M
24.27%6.41M
36.11%4.64M
23.60%2.62M
25.63%8.39M
Invest income
140.88%288.92K
196.19%8.9M
4,206.66%9.43M
-50.10%249.17K
-220.84%-706.71K
10.96%-9.25M
96.27%-229.69K
111.19%499.37K
85.18%-220.27K
-120.95%-10.39M
-Including: Investment income associates
--0
163.97%7.47M
467.65%8.54M
76.57%-366.21K
41.39%-706.71K
8.83%-11.68M
71.05%-2.32M
74.01%-1.56M
39.89%-1.21M
-29.42%-12.81M
Asset deal income
101.74%2.63K
145.87%487.73K
-154.17%-8.44K
-724.72%-44.13K
-399.07%-151.14K
-10.80%-1.06M
101.72%15.58K
229.70%7.06K
997.18%50.54K
-101.01%-959.58K
Other revenue
42.42%3.49M
12.13%20.1M
24.02%14.14M
-50.86%4.41M
-60.64%2.45M
-22.76%17.93M
-43.38%11.4M
-46.88%8.96M
-47.71%6.22M
15.63%23.21M
Operating profit
-3.95%98.06M
42.48%417.43M
21.01%306.39M
39.06%222.74M
36.21%102.08M
-2.74%292.98M
28.79%253.2M
10.49%160.17M
14.44%74.95M
4.72%301.25M
Add:Non operating Income
-94.45%277.55
87.27%331.42K
564.13%302.69K
395.67%203.35K
-85.31%5K
43.85%176.98K
-90.63%45.58K
-89.74%41.03K
126.50%34.05K
1,675.97%123.03K
Less:Non operating expense
635.27%2.16M
108.81%6.84M
174.36%5.88M
91.98%3.43M
-79.21%294.31K
-49.72%3.27M
-39.33%2.14M
1.81%1.79M
1,004.87%1.42M
310.45%6.51M
Total profit
-5.80%95.89M
41.76%410.92M
19.80%300.82M
38.56%219.51M
38.37%101.79M
-1.69%289.88M
29.73%251.11M
10.32%158.42M
12.53%73.57M
3.07%294.86M
Less:Income tax cost
-5.19%10.73M
41.83%49.67M
60.73%38.31M
109.18%30.47M
20.87%11.32M
4.93%35.02M
20.23%23.84M
-13.50%14.57M
16.22%9.37M
53.15%33.37M
Net profit
-5.87%85.16M
41.74%361.26M
15.50%262.51M
31.41%189.04M
40.92%90.47M
-2.53%254.86M
30.82%227.27M
13.49%143.86M
12.01%64.2M
-1.06%261.48M
Net profit from continuing operation
-5.87%85.16M
41.74%361.26M
15.50%262.51M
31.41%189.04M
40.92%90.47M
-2.53%254.86M
30.82%227.27M
13.49%143.86M
12.01%64.2M
-1.06%261.48M
Net profit of parent company owners
-5.87%85.16M
41.74%361.26M
15.50%262.51M
31.41%189.04M
40.92%90.47M
-2.53%254.86M
30.82%227.27M
13.49%143.86M
12.01%64.2M
-0.86%261.48M
Earning per share
Basic earning per share
-4.35%0.22
42.19%0.91
17.54%0.67
33.33%0.48
43.75%0.23
-3.03%0.64
29.55%0.57
12.50%0.36
14.29%0.16
-1.49%0.66
Diluted earning per share
-4.35%0.22
40.63%0.9
17.54%0.67
33.33%0.48
43.75%0.23
-3.03%0.64
29.55%0.57
12.50%0.36
14.29%0.16
-1.49%0.66
Other composite income
161.22%125.15K
87.94%106.77K
110.15%56.18K
-133.91%-204.43K
118.90%56.81K
-201.49%-553.19K
-66.93%602.86K
Other composite income of parent company owners
----
161.22%125.15K
87.94%106.77K
110.15%56.18K
----
-133.91%-204.43K
118.90%56.81K
-201.49%-553.19K
----
-66.93%602.86K
Total composite income
-5.87%85.16M
41.91%361.38M
15.52%262.61M
31.95%189.09M
40.92%90.47M
-2.83%254.66M
31.08%227.33M
12.57%143.3M
12.01%64.2M
-1.51%262.09M
Total composite income of parent company owners
-5.87%85.16M
41.91%361.38M
15.52%262.61M
31.95%189.09M
40.92%90.47M
-2.83%254.66M
31.08%227.33M
12.57%143.3M
12.01%64.2M
-1.31%262.09M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue -4.32%260.35M8.01%1.2B2.08%865.63M6.69%579.34M16.63%272.09M6.27%1.11B19.84%847.97M18.38%543.02M19.53%233.29M23.91%1.04B
Operating revenue -4.32%260.35M8.01%1.2B2.08%865.63M6.69%579.34M16.63%272.09M6.27%1.11B19.84%847.97M18.38%543.02M19.53%233.29M23.91%1.04B
Other operating revenue ----123.87%10.39M----117.10%6.52M-----53.55%4.64M-----39.70%3M----2.42%9.99M
Total operating cost -2.10%168.27M-1.20%784.42M-6.01%560.75M-6.45%358.79M2.44%171.88M6.76%793.98M14.08%596.6M17.82%383.54M21.11%167.79M12.32%743.67M
Operating cost 1.60%45.67M23.28%208.51M8.71%140.72M14.96%92.68M23.97%44.95M1.11%169.15M11.56%129.44M7.28%80.62M15.17%36.26M13.18%167.29M
Operating tax surcharges -8.26%3.01M163.40%13.18M167.96%9.93M173.10%6.98M313.89%3.28M7.10%5M25.10%3.7M24.66%2.56M1.88%791.51K25.46%4.67M
Operating expense -28.26%51.52M-6.90%334.05M-2.59%245.48M-7.01%149.13M9.73%71.81M8.90%358.82M13.04%252M11.08%160.38M21.16%65.44M8.46%329.49M
Administration expense -21.33%16.27M0.97%72.92M-1.52%57.37M-0.82%43.67M2.39%20.68M11.36%72.21M10.36%58.26M24.88%44.03M36.28%20.2M4.10%64.85M
Financial expense 171.34%7.4M20.09%-21.82M-124.97%-25.13M-135.90%-24.21M-217.92%-10.37M-5.65%-27.31M50.41%-11.17M55.73%-10.26M-803.82%-3.26M13.92%-25.85M
-Interest expense (Financial expense) 19.34%401.35K44.26%1.93M58.34%1.43M107.02%1.05M9.57%336.3K12.06%1.34M7.01%906.16K-21.72%508.59K-4.76%306.92K20.34%1.2M
-Interest Income (Financial expense) 13.91%-6.33M-16.09%-30.85M-19.77%-23.43M-23.66%-15.87M-19.85%-7.35M-38.65%-26.58M-48.57%-19.56M-51.79%-12.84M-67.87%-6.14M-213.90%-19.17M
Research and development 6.91%44.41M-17.83%177.59M-19.46%132.38M-14.77%90.53M-14.12%41.54M6.35%216.11M9.03%164.36M15.62%106.21M30.75%48.36M16.44%203.22M
Credit Impairment Loss 160.97%975.69K13.55%-26.12M-244.22%-26.83M-4.97%-5.73M-306.30%-1.6M-468.44%-30.22M-21.68%-7.79M-26.74%-5.45M121.30%775.67K39.15%-5.32M
Asset Impairment Loss -77.76%14.72K38.88%-4.98M99.99%-462.03100.70%55.92K1,222.22%66.22K39.73%-8.15M-5,783.80%-7.97M-3,045.07%-7.96M154.62%5.01K-4,373.69%-13.52M
Adjustment items of total operating cost --------------0.01-----------0.01------------
Other net revenue 219.73%5.98M118.72%4.12M-17.68%1.51M214.54%2.18M-80.20%1.87M-1,655.29%-21.99M-84.68%1.83M-94.11%693.5K6.51%9.45M-98.69%1.41M
Fair value change income -33.24%1.21M-34.68%5.73M-25.46%4.78M-30.11%3.24M-30.67%1.81M4.46%8.77M24.27%6.41M36.11%4.64M23.60%2.62M25.63%8.39M
Invest income 140.88%288.92K196.19%8.9M4,206.66%9.43M-50.10%249.17K-220.84%-706.71K10.96%-9.25M96.27%-229.69K111.19%499.37K85.18%-220.27K-120.95%-10.39M
-Including: Investment income associates --0163.97%7.47M467.65%8.54M76.57%-366.21K41.39%-706.71K8.83%-11.68M71.05%-2.32M74.01%-1.56M39.89%-1.21M-29.42%-12.81M
Asset deal income 101.74%2.63K145.87%487.73K-154.17%-8.44K-724.72%-44.13K-399.07%-151.14K-10.80%-1.06M101.72%15.58K229.70%7.06K997.18%50.54K-101.01%-959.58K
Other revenue 42.42%3.49M12.13%20.1M24.02%14.14M-50.86%4.41M-60.64%2.45M-22.76%17.93M-43.38%11.4M-46.88%8.96M-47.71%6.22M15.63%23.21M
Operating profit -3.95%98.06M42.48%417.43M21.01%306.39M39.06%222.74M36.21%102.08M-2.74%292.98M28.79%253.2M10.49%160.17M14.44%74.95M4.72%301.25M
Add:Non operating Income -94.45%277.5587.27%331.42K564.13%302.69K395.67%203.35K-85.31%5K43.85%176.98K-90.63%45.58K-89.74%41.03K126.50%34.05K1,675.97%123.03K
Less:Non operating expense 635.27%2.16M108.81%6.84M174.36%5.88M91.98%3.43M-79.21%294.31K-49.72%3.27M-39.33%2.14M1.81%1.79M1,004.87%1.42M310.45%6.51M
Total profit -5.80%95.89M41.76%410.92M19.80%300.82M38.56%219.51M38.37%101.79M-1.69%289.88M29.73%251.11M10.32%158.42M12.53%73.57M3.07%294.86M
Less:Income tax cost -5.19%10.73M41.83%49.67M60.73%38.31M109.18%30.47M20.87%11.32M4.93%35.02M20.23%23.84M-13.50%14.57M16.22%9.37M53.15%33.37M
Net profit -5.87%85.16M41.74%361.26M15.50%262.51M31.41%189.04M40.92%90.47M-2.53%254.86M30.82%227.27M13.49%143.86M12.01%64.2M-1.06%261.48M
Net profit from continuing operation -5.87%85.16M41.74%361.26M15.50%262.51M31.41%189.04M40.92%90.47M-2.53%254.86M30.82%227.27M13.49%143.86M12.01%64.2M-1.06%261.48M
Net profit of parent company owners -5.87%85.16M41.74%361.26M15.50%262.51M31.41%189.04M40.92%90.47M-2.53%254.86M30.82%227.27M13.49%143.86M12.01%64.2M-0.86%261.48M
Earning per share
Basic earning per share -4.35%0.2242.19%0.9117.54%0.6733.33%0.4843.75%0.23-3.03%0.6429.55%0.5712.50%0.3614.29%0.16-1.49%0.66
Diluted earning per share -4.35%0.2240.63%0.917.54%0.6733.33%0.4843.75%0.23-3.03%0.6429.55%0.5712.50%0.3614.29%0.16-1.49%0.66
Other composite income 161.22%125.15K87.94%106.77K110.15%56.18K-133.91%-204.43K118.90%56.81K-201.49%-553.19K-66.93%602.86K
Other composite income of parent company owners ----161.22%125.15K87.94%106.77K110.15%56.18K-----133.91%-204.43K118.90%56.81K-201.49%-553.19K-----66.93%602.86K
Total composite income -5.87%85.16M41.91%361.38M15.52%262.61M31.95%189.09M40.92%90.47M-2.83%254.66M31.08%227.33M12.57%143.3M12.01%64.2M-1.51%262.09M
Total composite income of parent company owners -5.87%85.16M41.91%361.38M15.52%262.61M31.95%189.09M40.92%90.47M-2.83%254.66M31.08%227.33M12.57%143.3M12.01%64.2M-1.31%262.09M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More